TipRanks
Go Ultimate55% OFF

Rasna Therapeutics (RASP) Income Statement

Rasna Therapeutics Income Statement

Last quarter (Q2 2024), Rasna Therapeutics's total revenue was $0.00. In Q2, Rasna Therapeutics's net income was $-95.52K. See Rasna Therapeutics’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementSep 23Sep 22Sep 21Sep 20Sep 19
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
$ 0.00$ 0.00$ -314.00$ -1.64K―
$ 4.24M$ 383.91K$ 247.81K$ 556.50K$ 915.17K
Depreciation and Amortization$ 184.21K$ 314.00$ 314.00$ 1.64K$ 3.47K
$ -4.05M$ 254.72K$ -247.69K$ -555.00K$ -912.93K
$ -4.24M$ 141.09K$ -248.00K$ -5.43M$ -915.17K
$ -204.00K$ -828.00K$ -628.00K$ 79.15K$ -28.79K
$ -4.44M$ -687.00K$ -876.00K$ -5.35M$ -943.96K
$ -4.44M$ -687.00K$ -876.00K$ -5.35M$ -936.38K
Per Share Metrics
Basic EPS$ -0.01$ -0.01$ -0.01$ -0.08$ -0.01
Diluted EPS$ -0.01$ -0.01$ -0.01$ -0.08$ -0.01
Weighted Average Shares Outstanding578.02M68.66M68.91M68.91M68.91M
Weighted Average Shares Outstanding (Diluted)578.02M111.43M68.91M68.91M68.91M

Currency in USD

Rasna Therapeutics Earnings and Revenue History

-6M-4M-2M00 %0.4 %0.8 %1.2 %EarningsProfit Margin201820192020202120222023RevenueEarningsProfit Margin